FDA approves updated Covid-19 vaccines for dominant XFG variant
World2 sources2 countries🔦 Under-reported25m ago
On Thursday, the US Food and Drug Administration approved updated COVID-19 vaccines tailored for the dominant XFG variant, clearing the way for manufacturers to begin shipping new doses to pharmacies and physicians' offices across the country. The approvals encompass new mRNA formulations from Pfizer-BioNTech and Moderna, as well as a non-mRNA shot.
The regulatory decision allows distribution to commence immediately. However, reports note that ongoing uncertainty persists regarding insurance coverage for the updated inoculations, and specific eligibility is targeted toward individuals at higher risk.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
The Guardian World (GB)Highlights distribution greenlight alongside persistent confusion surrounding patient insurance coverage.
The Hill (US)Emphasizes the targeted approval for high-risk individuals and the specific manufacturers involved.
Newz